November 25, 2015
View Full PaperType 1 diabetes immunotherapy using polyclonal regulatory T cells
Key Points
Key points are not available for this paper at this time.
Abstract
Autologous regulatory T cells can be expanded and are well tolerated in patients with recent-onset type 1 diabetes.